Federal Circuit hears arguments in Zarxio ‘patent dance’ row

08-06-2015

Federal Circuit hears arguments in Zarxio ‘patent dance’ row

Violetsunset / Shutterstock.com

The US Court of Appeals for the Federal Circuit has heard oral arguments in Amgen v Sandoz, a case that should determine whether it is mandatory for biosimilar applicants to engage in the so-called patent dance.


US Court of Appeals for the Federal Circuit, patent dance, Amgen, Sandoz, Zarxio, biosimilars, Neupogen, filgrastim

LSIPR